The DOI matches its Crossref record; 76 of the 80 references it cites were found in a registry or an index.
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Open accessPublished version of a preprint
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is causing a global pandemic, and cases continue to rise. Most infected individuals experience mildly symptomatic coronavirus disease 2019 (COVID-19), but it is unknown whether this can induce persistent immune memory that could contribute to immunity. We performed a longitudinal assessment of individuals recovered from mild COVID-19 to determine whether they develop and sustain multifaceted SARS-CoV-2-specific immunological memory. Recovered individuals developed SARS-CoV-2-specific immunoglobulin (IgG) antibodies, neutralizing plasma, and memory B and memory T cells that persisted for at least 3 months. Our data further reveal that SARS-CoV-2-specific IgG memory B cells increased over time. Additionally, SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral function: memory T cells secreted cytokines and expanded upon antigen re-encounter, whereas memory B cells expressed receptors capable of neutralizing virus when expressed as monoclonal antibodies. Therefore, mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks of antiviral immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Among cytokine profiles of spike-responsive memory T cells, production was dominated by the expression of IL-2 and IFN-γ that were highly expressed by CCR6− subsets.32, 33”
From Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial (2022) · cites this paper as [33]
In the citing paper
“However, neutralizing antibody responses decay rapidly in early convalescence9,14–17.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [9]
In the citing paper
“We and others have shown that SARS-CoV-2-specific memory B cells accumulate over the first few months after initial infection2,3,8,9,28 (Fig. 1a)”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [9]
In the citing paper
“The observations that frequencies of circulating memory B cells continue to increase for several months after recovery from COVID-19 (refs2,3,8,9,28), when most other responses are declining (Fig. 1a), suggest that recall of B cell memory may provide a mechanism to extend the duration of antibody-dependent protection in the face of waning serological titres.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [9]
In the citing paper
“SARS-CoV-2 infection rapidly elicits nAbs (16, 21–24) that decline, but remain detectable, over several months (25–29).”
From mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021) · cites this paper as [26]
In the citing paper
“SARS-CoV-2 infection can induce the production of neutralizing antibodies, and these antibodies are believed to contribute to protection from reinfection (Rodda et al., 2020; Wajnberg et al., 2020).”
From SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) · cites this paper as Rodda et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 1×
“Antigen-specific memory CD4 T cells proliferate to re-seed the memory pool and generate effector cells upon antigen reexposure (Sallusto et al., 1999).”
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Self-citationSARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 2×
“(legend continued on next page) ll Cell 184, 169–183, January 7, 2021 171 Article ll Article years, depending upon the specific viral infection (Slifka and Ahmed, 1996).”
Research works printed but not linked: 2
- Nellore, 2019, Fcrl5 and T-bet define influenza-specific memory B cells that predict long-lived antibody responses, bioRxiv
- Wajnberg, 2020, SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months, medRxiv
Cited by
Sorted by citations
Items 501–600 of 644
In vivo chemogenetic RNA editing of macrophages by bioengineered viruses for sepsis treatment
Xi, W., Xu, Y., Bao, W., Ding, Z., Hu, X., Yang, J., Yan, X., & Ping, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-67655-y · Cited by 2
Wang, L., Xu, R., Huang, D., Peng, P., Sun, K., Hu, J., Liu, B., Fang, L., Zhang, L., Sun, X., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07048-x · Cited by 2
Natural immune response and protection from SARS-CoV-2 reinfection
Margiotti, K., Fabiani, M., Mesoraca, A., & Giorlandino, C. (2021) · Acta Virologica · doi:10.4149/av_2021_401 · Cited by 2
Dynamics of B-Cell Responses after SARS-CoV-2 Vaccination in Spain
José-Cascón, M. S., de la Varga‐Martínez, R., Campos‐Caro, A., & Rodriguez, C. S. (2022) · Vaccines · doi:10.3390/vaccines10101615 · Cited by 2
Dynamics of SARS-CoV-2-Specific B Cell Memory Responses in Infected and Vaccinated Individuals
Fabiani, M., Margiotti, K., Monaco, F., Viola, A., Cima, A., Mesoraca, A., & Giorlandino, C. (2023) · Viral Immunology · doi:10.1089/vim.2022.0197 · Cited by 2
Zhu, Q., Wang, L., Hu, X., Zhang, Y., Huang, T., He, T., Chen, Z., Zhang, G., Peng, M., Chen, M., et al. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00108 · Cited by 2
Zhan, H., Xie, Y., Liu, Y., Cheng, L., Xu, Y., Qu, X., Li, C., Guo, X., Li, H., Wang, Y., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29446 · Cited by 2
SARS‐CoV‐2 seroprevalence and associated factors among people living with HIV in Sierra Leone
Sun, W., Song, J., Lakoh, S., Chen, J., Jalloh, A. T., Sahr, F., Sevalie, S., Jiba, D. F., Kamara, I. F., Xin, Y., et al. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1338 · Cited by 2
Evaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2
Islas-Vázquez, L., Alvarado-Alvarado, Y. C., Cruz‐Aguilar, M., Velázquez-Soto, H., Villalobos-Gonzalez, E., Ornelas-Hall, G., Pérez‐Tapia, S. M., & Martínez, M. D. C. J. (2023) · Vaccines · doi:10.3390/vaccines11121787 · Cited by 2
Pasev, M., Trifonova, A., Velichkov, A., & Terzieva, V. I. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112084 · Cited by 2
Whither immunity? The search for effective, durable immunity to coronavirus disease 2019 (COVID-19)
Henderson, D. K., Haessler, S., Hayden, M. K., Weber, D. J., Babcock, H. M., Malani, A. N., Wright, S. B., Murthy, A. R., Guzman‐Cottrill, J. A., Rock, C., et al. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.442 · Cited by 2
Humoral immunity to SARS-CoV-2 among the population of Murmansk region amid COVID-19 epidemic
Popova, A. Y., Ezhlova, E. B., Melnikova, A. A., Лукичева, Л. А., Nikitina, N. I., Lyalina, L. V., Смирнов, В. С., Koltsov, N. S., Ermakova, M. V., Kubashev, A. K., et al. (2021) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2021-13-1-17-27 · Cited by 2
Silva, D. F. E., Silva, P. D., Torgal, A., Braga, S., Rocha, D., Ochoa, C., Oliveira, Á. M., Rocha, L., Dias, J. M., & Baldaque, I. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.16336 · Cited by 2
Grigorova, I. (2021) · System Biology and Physiology Reports · doi:10.52455/sbpr.01.202103011 · Cited by 2
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
Deisenhammer, F., Bauer, A., Kavelar, C., Rudzki, D., Rössler, A., Kimpel, J., Borena, W., & Reindl, M. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01985-x · Cited by 2
In the shadow of antibodies: how T cells defend against COVID-19
Pisetsky, D. S., & Winthrop, K. L. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221952 · Cited by 2
Immunity to SARS‐CoV ‐2 infection*
Pepper, M. (2022) · Immunological Reviews · doi:10.1111/imr.13117 · Cited by 2
Self-citationA deconvolution approach to modelling surges in COVID-19 cases and deaths
Melnyk, A., Kozarov, L., & Wachsmann‐Hogiu, S. (2022) · Scientific Reports · doi:10.1038/s41598-023-29198-4 · Cited by 2
'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19Preprint
García-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., Al-Delfi, Z., Abayasingam, A., Agapiou, D., Gummow, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3859298 · Cited by 2
Hale, M. R., Takehara, K. K., Thouvenel, C. D., Moustafa, D. A., Repele, A., Fontana, M. F., Netland, J., McNamara, S., Gibson, R. L., Goldberg, J. B., et al. (2024) · eLife · doi:10.7554/elife.98851 · Cited by 2
Self-citationKaraca, A., Günçıkan, M. N., Sözmen, N. N., Karadağ, G. G., & Yılmaz, M. (2021) · Medeniyet Medical Journal · doi:10.5222/mmj.2021.00921 · Cited by 1
Vaccine-induced immune responses against SARS-CoV-2 infections
Garg, M. K., Maralakunte, M., Kumar, Y., Bhujade, H., Sehgal, I. P., Suri, V., & Garg, S. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00024 · Cited by 1
Friedman, S. M., Li, J., Thomas, P., Gurumurthy, M., Siderits, R. H., Nepomich, A., & Lifshitz, E. I. (2022) · Journal of Community Health · doi:10.1007/s10900-022-01142-z · Cited by 1
COVID-19 induced ARDS: immunopathology and therapeutics
Das, S., Sharma, T., Bhardwaj, A., & Srivastava, R. K. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00101 · Cited by 1
Studying the Humoral Response against SARS‐CoV‐2 in Cuban COVID‐19 Recovered Patients
Orosa-Vázquez, I., Díaz-Hernández, M., Rosales, Y. Z., Amada, K., Chang, J., Relova-Hernández, E., Tundidor, Y., Balbuena, H. R., Benítez, G. M., Rives, B. T., et al. (2024) · Journal of Immunology Research · doi:10.1155/2024/7112940 · Cited by 1
Jiang, W., Wu, J., He, J., Xia, A., Wu, W., Gao, Y., Zhang, Q., Peng, X., Jiang, Q., Xue, S., et al. (2024) · Vaccines · doi:10.3390/vaccines12111204 · Cited by 1
Laudański, K., Ahmed, A. S., Mahmoud, M. A., Antar, M., & Gad, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052349 · Cited by 1
Mairhofer, M., Kausche, L., Kaltenbrunner, S., Pammer, M., Ghanem, R., Stegemann, M., & Schmitt, C. A. (2025) · iScience · doi:10.1016/j.isci.2025.113727 · Cited by 1
Advances in nanotechnology-augmented T cell-based novel cancer immunotherapies
He, X., Du, J., Zeng, L., Tong, F., Ma, J., Zeng, N., Hu, C., Gao, H., & Zhang, J. (2025) · Nano Research · doi:10.26599/nr.2025.94908299 · Cited by 1
Pone, E. J., Felgner, J. H., Hernandez‐Davies, J. E., Gach, J. S., Albin, T. J., & Davies, D. H. (2025) · Cytometry Part A · doi:10.1002/cytoa.70000 · Cited by 1
Temporal pattern of humoral immune response in mild cases of COVID-19
Campos, I. M. P., Marques, M., Peiter, G. C., Brandalize, A. P. C., dos Santos, M. B., de Melo, F. F., & Teixeira, K. N. (2023) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v14.i2.40 · Cited by 1
Molina, L. D. P., Bravo‐Gallego, L. Y., Nozal, P., Serrano, Y. S., Martínez‐Feito, A., Reche-Yebra, K., González‐Torbay, A., de la Cámara, R. C., Gianelli, C., Cámara, C., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1136308 · Cited by 1
Bozhkova, M., Kalfova, T., Petrov, S., Velyanova, T., Taskov, H. B., Nikolova, M. H., & Murdjeva, M. (2023) · PROBLEMS of Infectious and Parasitic Diseases · doi:10.58395/wc1f1t22 · Cited by 1
Bassanello, M., Geppini, R., Bonsembiante, E., Coli, U., Farencena, A., D'Aquino, M., Gambaro, A., Buja, A., & Baldovin, T. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1223109 · Cited by 1
Comprehensive Risk Assessment of Infection Induced by SARS-CoV-2
Megha, K. B., Reshma, S. C., Amir, S., Krishnan, M. A., Ahlawat, S., Alka, R., & Mohanan, P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03682-4 · Cited by 1
Epidemiological contemplation for a currently pragmatic COVID-19 health passport: a perspective
Ambalavanan, R., Snead, R. S., Marczika, J., & Malioukis, A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1347623 · Cited by 1
Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers
Ramos, A., Martins, S., Marinho, A. S., Norton, P. M. P. N. S., Cardoso, M. J., & Guimarães, J. T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303244 · Cited by 1
Wang, X., Yang, X., Zhang, X., Yan, H., Jin, J., Ma, Z., Duan, J., Zhang, G., Huang, T., Li, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1554409 · Cited by 1
Gonzaga, A., Martı́nez, G., Maciá, L., Anton-Bonete, M., Cahuana, G. M., Tejedo, J. R., Zorrilla-Muñoz, V., Fernández, E., Andreu, E., Eguizábal, C., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13081801 · Cited by 1
Coordinated and sustained immune memory responses after mild COVID-19
Alrubayyi, A. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00450-6 · Cited by 1
Estimating COVID-19 Virus Prevalence from Records of Testing Rate and Test Positivity
Everts, A. J. W. (2021) · Global Biosecurity · doi:10.31646/gbio.98 · Cited by 1
Experiencia y manejo de la COVID-19 en Lima Norte
Atencio, C. R. (2021) · Revista Médica Basadrina · doi:10.33326/26176068.2021.2.1057 · Cited by 1
Pathogenesis of covid-19: principles of viral infection and immune response
Beneš, J., & Nováková, D. (2021) · Intervenční a akutní kardiologie · doi:10.36290/kar.2021.023 · Cited by 1
Hawaldar, R., Sodani, S., Sodani, V., & Sodani, R. K. (2021) · The Journal of Community Health Management · doi:10.18231/j.jchm.2021.017 · Cited by 1
Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe
Untersmayr, E., Förster‐Waldl, E., Bonelli, M. M., Boztuǧ, K., Brunner, P. M., Eiwegger, T., Eller, K., Göschl, L., Grabmeier‐Pfistershammer, K., Hötzenecker, W., et al. (2021) · Allergo Journal · doi:10.1007/s15007-021-4848-z · Cited by 1
Adoptive T-cell therapies to overcome T cell-dependent immune dysregulations in COVID-19
Taş, S. K., Uzunoğlu, M. S., Uzunoğlu, A. S., Kırkık, D., Altunkanat, D., & Kalkanli, N. (2021) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2109-85 · Cited by 1
Impacto da estrutura de detenção na ocorrência de infecção por SARS-CoV-2 em jovens detentos
Borges, L. P., Guimarães, A. G., de Souza, D. R. V., Martins, A. F., Neto, J. M. D. R., Santos, A. A., da Invenção, G. B., Matos, I. L. S., dos Santos, K. A., Souza, N. A. A., et al. (2022) · Research Society and Development · doi:10.33448/rsd-v11i1.24680 · Cited by 1
DeSantis, S. M., León‐Novelo, L., Swartz, M. D., Yaseen, A. S., Valerio-Shewmaker, M. A., Talebi, Y., Brito, F. A., Ross, J. A., Kohl, H. W., Messiah, S. E., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273694 · Cited by 1
Gurevich, M., Zilkha‐Falb, R., Sonis, P., Magalashvili, D., Dolev, M., Mandel, M., Menascu, S., & Achiron, A. (2022) · Pediatric Allergy and Immunology · doi:10.1111/pai.13863 · Cited by 1
Downregulation of sCD40 and sCTLA4 in Recovered COVID-19 Patients with Comorbidities
Méndez-Frausto, G., Godina-González, S., Rivas-Santiago, C., Nungaray-Anguiano, E., Mendoza‐Almanza, G., Rivas-Santiago, B. T., Galvan-Tejada, C. E., & Gonzalez-Curiel, I. E. (2022) · Pathogens · doi:10.3390/pathogens11101128 · Cited by 1
Symptomatic reinfection with COVID-19: A case-report study in Iran
Kalurazi, T. Y., Amini‐Salehi, E., Rahimi-Shamami, S., Poursmail, R., Joukar, F., Hassanipour, S., & Mansour‐Ghanaei, F. (2022) · Journal of Current Biomedical Reports · doi:10.52547/jcbior.3.2.98 · Cited by 1
Vladimirov, I. S., Zhdanova, A. S., Bolashova, E., Mukhin, V. E., Makarov, V. V., Yudin, V. S., & Александрович, К. С. (2023) · Immunologiya · doi:10.33029/0206-4952-2023-44-6-788-801 · Cited by 1
Epperly, D. E., Rinehart, K. R., & Caney, D. N. (2020) · medRxiv · doi:10.1101/2020.10.03.20206110 · Cited by 1
Mendes-Corrêa, M. C., Villas-Boas, L. S., Bierrenbach, A. L., de Paula, A. V., Tozetto‐Mendoza, T. R., Leal, F. E., Freire, W. S., Paião, H. G. O., Ferraz, A. B. C., & Witkin, S. S. (2021) · medRxiv · doi:10.1101/2021.05.11.21256908 · Cited by 1
Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and AgePreprint
Murrell, A. E., Eyoh, E., Shaffer, J. G., Dietrich, M. L., Trinh, I. V., Yockachonis, T. J., Bai, S., Zheng, C. Y., Mayne, C. V., Cabrera, S. E., et al. (2022) · medRxiv · doi:10.1101/2022.04.22.22274032 · Cited by 1
Zhang, J., He, R., Liu, B., Zheng, X., Wu, Q., Wen, B., Wang, Q., Liu, Z., Chang, F., Hu, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.09.503302 · Cited by 1
Hale, M. R., Takehara, K. K., Thouvenel, C. D., Moustafa, D. A., Repele, A., Fontana, M. F., Netland, J., McNamara, S., Gibson, R. L., Goldberg, J. B., et al. (2024) · eLife · doi:10.7554/elife.98851.1 · Cited by 1
Self-citationHale, M. R., Takehara, K. K., Thouvenel, C. D., Moustafa, D. A., Repele, A., Fontana, M. F., Netland, J., McNamara, S., Gibson, R. L., Goldberg, J. B., et al. (2024) · eLife · doi:10.7554/elife.98851.2 · Cited by 1
Self-citationGrier, J. T. (2021) · The Conversation · doi:10.64628/aai.4tan6vn6g · Cited by 1
Reinfeccion de COVID-19: Respuesta inmune y posibles causas
Pérez, E. S. (2020) · RECIMUNDO · doi:10.26820/recimundo/4.(4).noviembre.2020.92-100
Long-Term Duration of Antibody Response to SARS CoV-2 in One of the Largest Slums of Buenos AiresPreprint
Pagotto, V. L., Luna, L., Salto, J., Manslau, M. W., Figar, S., Mistchenko, A. S., Carciofi, G., Weinberger, N., COVIDAR Group, Saldaño, A. M. G., et al. (2021) · medRxiv · doi:10.1101/2021.03.05.21253010
Acute treatment with monoclonal antibodies: their design and their use
Kelleher, A. D. (2021) · Microbiology Australia · doi:10.1071/ma21011
A Mathematical Model of U.S. COVID-19 Deaths, Incidence and Quarantine Adjusted Herd Immunity by AgePreprint
Lovvoll, V. (2021) · Research Square · doi:10.21203/rs.3.rs-343570/v1
COVID-19: The extraction of the effective reproduction number from the time series of new casesPreprint
Matsinos, E. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2105.03330
The Role of the Host Immune System in SARS-CoV-2 Infection
Malekshahi, A., & Khanizadeh, S. (2020) · یافته · doi:10.32592/yafteh.2021.23.2.11
Capacidad de respuesta inmunitaria al COVID-19 en pacientes en hemodiálisis
Boldoba, N. B., Vasquez, M. G., Gaitan, D., Alamo, C., Rodríguez, J. R., Pérez, K. M., Sánchez, M. G., Basterrechea, M. A., & de Arriba, G. (2021) · Revista de Investigación y Educación en Ciencias de la Salud (RIECS) · doi:10.37536/riecs.2021.6.1.253
Kedzierska, K., Habel, J. R., Chua, B. Y. L., Kedzierski, Ł., Selva, K. J., Damelang, T., Haycroft, E. R., Nguyen, T. H. O., Koay, H., Nicholson, S. R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-745648/v1
Schmidt, J., Blessing, F., & Gürtler, L. G. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1550-0001
Nag, D. S., Mishra, M., Chaudhry, R., Rana, F., Rai, S., Mehta, N., & Gupta, M. (2021) · Cureus · doi:10.7759/cureus.18097
Ali, I. H., & Abdulamir, A. S. (2021) · PubMed Central · doi:10.22092/ari.2021.356135.1785
Inmunidad humoral natural al año tras infección por SARS-CoV-2 en pacientes hospitalizados
Cabanes, L., Rubio, C., Martinez, O., & Naval, E. (2021) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2021.10.012
COVID-19 variants, available treatments, and vaccinations: An overview study
Mohammed, A. H., Suhaimi, A. M., & Hassan, B. A. R. (2021) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v1i.42
The effectiveness of the immune responses to SARS-CoV-2
Salih, B. A. (2022) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000306
Hartshorne, J., & Villiers, P. J. T. D. (2021) · AfricArXiv (OSF Preprints) · doi:10.31730/osf.io/e7udq
An oral pathologist's tryst with COVID 19
Indu, S. (2021) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_291_21
Cancer Patients Have Necessary Been COVID-19 Vaccinated
Cheepsattayakorn, A., Cheepsattayakorn, R., & Siriwanarangsun, P. (2021) · Trends in Internal Medicine · doi:10.33425/2771-5906.1005
COVID-19 pandemisinin ilk yılında öğrendiklerimiz
Kılbaş, İ., Kilbaş, E. P. K., & Çiftçi, İ. H. (2021) · Hitit Medical Journal · doi:10.52827/hititmedj.937077
Where Did We Go Wrong with This Pandemic?
Gernon, L. W. (2022) · Open Journal of Emergency Medicine · doi:10.4236/ojem.2022.102006
Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients
Cabanes, L., Rubio, C., Martínez, O., & Naval, E. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.04.007
Habel, J. R., Chua, B. Y. L., Kedzierski, Ł., Selva, K. J., Damelang, T., Haycroft, E. R., Nguyen, T. H. O., Koay, H., Nicholson, S. R., McQuilten, H. A., et al. (2021) · medRxiv · doi:10.1101/2021.08.21.21262399
(2021) · Microbiology Australia · doi:10.1071/mav42n1
Laboratory diagnosis of emerging human infections by SARS-COVID-19: Prevalence and challenges
Nigam, S., Vijay, U., & Kour, B. (2022) · Novel Research in Microbiology Journal · doi:10.21608/nrmj.2022.244415
Paramita, S., Khotimah, S., Marwan, M., Isnuwardana, R., Fitriany, E., & Nufus, A. Z. S. Z. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9957
Likelihood of COVID-19 reinfection in an urban community cohort in Massachusetts
Casey, S. M., Legler, A., Hanchate, A. D., & Perkins, R. B. (2022) · Dialogues in Health · doi:10.1016/j.dialog.2022.100057 · Cited by 1
T Cell Immune Responses against SARS-CoV-2 in the With Corona Era
Oh, J.-E. (2022) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2022.28.4.211
Chowdhury, S. R., Chakrabarty, S., Chakraborti, M., & Das, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85730-7.00009-6
Imunomodulação da expressão de PD-1 em monócitos e linfócitos T e B na infecção por SARS-CoV-2
Beserra, D. R. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2022.tde-16022023-122405
Reactions to SARS-CoV-2: The Effectiveness of the Body’s Immunological Memory
Saridena, A., Saridena, A., & Kethar, J. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i1.4359
A critical appraisal of the toxicological aspects of COVID-19 and its vaccines
Νikolouzakis, Τ. Κ., Călina, D. C., Brooks, B. D., Docea, A. O., & Tsatsakis, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00590-x
Research progress on the neutralizing antibody response to SARS-CoV-2
Teng, S., & Qu, X. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0084
Comparative Study of IgG Between Iraqi Covid-19 Patients and Vaccinated Individuals
Mutlaq, S. T., & Mahdi, R. H. (2023) · Bionatura · doi:10.21931/rb/css/2023.08.02.27
Wu, C.-Y., Tseng, Y.-C., Kao, S.-E., Wu, L., Hou, J.-T., Yang, Y., Hsiao, P., & Chen, J.-R. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105759
Immunity to SARS-CoV-2 after vaccination and previous infection: COVID - 19 immunity study, NamibiaPreprint
Hedimbi, H., Nepolo, E., Worwui, A. K., Nendongo, A., Haidula, L., & Nakambale, H. N. (2023) · Research Square · doi:10.21203/rs.3.rs-3706808/v1
Cellular Immunity in Individuals Classified by Antibody, After COVID-19 Infection/Vaccine
Yılmaz, N. S., Öztürk, R., Şen, B., & Ulukanlıgil, M. (2023) · Journal of Turkish Clinical Biochemistry · doi:10.56615/tkbd.2023.20
Memoria inmunológica y reinfección por SARS-CoV-2/COVID-19
Ladino, A. M. F., Santacruz, P. R., Delgado, A. M. O., & Hernández, J. P. R. (2023) · Pediatría · doi:10.14295/rp.v56i3.295
Saeb, S., Talei, G. R., Ghaziasadi, A., Letafati, A., Khanizadeh, S., & Jamalidoust, M. (2024) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-142644
de Oliveira, J. R. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-24082023-110203
Laudański, K., Mahmoud, M. A., Sayed, A., Susztak, K., Mathew, A., & Chen, J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073714
Metadata
- Authors
- Rodda, L. B., Netland, J., Shehata, L., Pruner, K. B., Morawski, P. A., Thouvenel, C. D., Takehara, K. K., Eggenberger, J., Hemann, E. A., Waterman, H. R., Fahning, M. L., Chen, Y., Hale, M., Rathe, J., Stokes, C., Wrenn, S., Fiala, B., Carter, L., Hamerman, J. A., King, N. P., Gale, M., Campbell, D. J., Rawlings, D. J., & Pepper, M.
- Affiliations
- University of Washington (US)
- Benaroya Research Institute (US)
- Corresponding author
- Pepper, Marion
- ORCID
- Rodda, Lauren B.
- Netland, Jason
- Shehata, Laila
- Pruner, Kurt B.
- Morawski, Peter A.
- Thouvenel, Christopher D.
- Takehara, Kennidy K.
- Eggenberger, Julie
- Hemann, Emily A.
- Waterman, Hayley R.
- Fahning, Mitchell L.
- Chen, Yu
- Hale, Malika
- Stokes, Caleb
- Wrenn, Samuel
- Fiala, Brooke
- Carter, Lauren
- Hamerman, Jessica A.
- King, Neil P.
- Gale, Michael
- Campbell, Daniel J.
- Rawlings, David J.
- Pepper, Marion
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 184
- Issue
- 1
- Pages
- 169-183.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC7682481
- OpenAlex
- W3107730772
- Cited by
- 647
- References
- 80
- Citations by year
- 2026: 10 · 2025: 30 · 2024: 46 · 2023: 85 · 2022: 171 · 2021: 278
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institutes of Health
- Burroughs Wellcome Fund
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, mild COVID-19, immunological memory, memory B cells, memory T cells, neutralizing antibodies, IgG, long-term immunity, cytokine production, monoclonal antibodies, antiviral immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
